Term: Drug Program Information Network (DPIN) Data

Printer friendly

Glossary Definition

Last Updated: 2013-03-12

Definition:

An electronic, on-line, point-of-sale prescription drug database that connects Manitoba Health and pharmacies in Manitoba. The DPIN system generates complete drug profiles for each client including all transactions at the point of distribution. Information about pharmaceutical dispensations, prescriptions identified as potential drug utilization problems, non-adjudicated prescriptions, ancillary programs, and non-drug products is captured in real time for all Manitoba residents (including Registered First Nations), regardless of insurance coverage or final payer. Note that the prescription's indication (the physician's prescribing intent) is not collected and must be inferred from other data. Services not captured in the drug database include hospital pharmacies, nursing stations, ward stock, and outpatient visits at CancerCare Manitoba.

For more information on DPIN data, see the:

• Drug Program Information Network (DPIN) Data Description that contains a brief summary of the content of the data set and information on the Source Agency, Purpose, Years, Type, Size, Data Level, Components, Scope, Data Collection Method, Data Highlights, Data Cautions, Access Requirements, More Information, and Last Updated date;
  
  
• MCHP Metadata Repository - Drug Program Information Network (DPIN) - [Internal Access Only] - for technical and programming related information, including an Overview, Data Model, Data Quality, Data Dictionary, Documents and Reports, and Blog.

NOTE: In MCHP research, the Drug Program Information Network (DPIN) data has also been referred to as the Prescription Drug Database.

Related concepts 

• Acute Myocardial Infarction (AMI) / Myocardial Infarction (MI) - Definition, Rates and Post-AMI Management
• Adjusted Clinical Group® (ACG®) - Relative Cost Weights
• Adjusted Clinical Groups® (ACG®) - Overview
• American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic Classification System
• Anatomical Therapeutic Chemical (ATC) Classification System
• Arthritis - Measuring Prevalence
• Asthma - Measuring Prevalence
• Asthma Care Controlled by Medication Use
• Attention-Deficit Hyperactivity Disorder (ADHD)
• Benzodiazepine Use / Benzodiazepine Dispensations
• Calculating Costs/Expenditures for Pharmaceuticals
• Canadian Network for Observational Drug Effect Studies (CNODES)
• Concurrency
• Costing Methods: An Overview of Costing Health Services in Manitoba
• Costing Using the 1999 Cost List for Manitoba Health Services
• Creating Drug Identification Number (DIN) Lists Using the SPD Server Updated DIN Master (UDM) File
• Depression - Defining in Administrative Data
• Diabetes - Measuring Prevalence
• Diabetes in Pregnancy - Differentiating Between Maternal Pre-Gestational Diabetes and Gestational Diabetes
• Discrepancies Between MCHP and Manitoba Health Published Reports
• Dose Intensity
• Drug Classification Systems
• Duration of Pharmaceutical Use
• Family Income / Household Income - Extracting from DPIN Application Files
• Hormone Replacement Therapy (HRT) Use
• Hypertension - Measuring Prevalence
• Ischemic Heart Disease (IHD) / Coronary Heart Disease (CHD) - Measuring Prevalence
• Mental Disorder / Mental Health Disorder / Mental Health Illness Classification
• Mood and Anxiety Disorders - Measuring Prevalence
• Osteoporosis - Measuring Prevalence
• Over the Counter Drugs - Identification
• Palliative Care - Data Sources and Method of Identification
• Persistence of Pharmaceutical Use
• Smoking Cessation Prescriptions
• Use and Identification of Specific Drugs in Clinical Research

Related terms 

• Drug Data Support Files
• Drug Program Information Network (DPIN)
• End of life Prescription Drugs
• Erectile Dysfunction (ED)
• Manitoba Population Research Data Repository (Repository)
• Master (Common) Formulary
• Nursing Home Drug Program Data
• Pharmaceutical Claims
• Prescription Cost

Links 

• MCHP Data Repository - Drug Program Information Network (DPIN) Data Description

References 

• Smith M, Finlayson G, Martens P, Dunn J, Prior H, Taylor C, Soodeen RA, Burchill C, Guenette W, Hinds A. Social Housing in Manitoba. Part II: Social Housing and Health in Manitoba: A First Look. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] (View)

Term used in 

• Chateau D, Enns M, Ekuma O, Koseva I, McDougall C, Kulbaba C, Allegro E. Evaluation of the Manitoba IMPRxOVE Program. Winnipeg, MB: Manitoba Centre for Health Policy, 2015. [Report] [Summary] (View)
• Fransoo R, Martens P, The Need to Know Team, Prior H, Burchill C, Koseva I, Bailly A, Allegro E. The 2013 RHA Indicators Atlas. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] [Additional Materials] (View)
• Martens P, Nickel N, Forget E, Lix L, Turner D, Prior H, Walld R, Soodeen RA, Rajotte L, Ekuma O. The Cost of Smoking: A Manitoba Study. Winnipeg, MB: Manitoba Centre for Health Policy, 2015. [Report] [Summary] [Updates and Errata] [Additional Materials] (View)
• Smith M, Finlayson G, Martens P, Dunn J, Prior H, Taylor C, Soodeen RA, Burchill C, Guenette W, Hinds A. Social Housing in Manitoba. Part II: Social Housing and Health in Manitoba: A First Look. Winnipeg, MB: Manitoba Centre for Health Policy, 2013. [Report] [Summary] (View)